Luigi Bubacco

10.0k total citations · 2 hit papers
195 papers, 7.7k citations indexed

About

Luigi Bubacco is a scholar working on Neurology, Molecular Biology and Cell Biology. According to data from OpenAlex, Luigi Bubacco has authored 195 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Neurology, 82 papers in Molecular Biology and 58 papers in Cell Biology. Recurrent topics in Luigi Bubacco's work include Parkinson's Disease Mechanisms and Treatments (86 papers), Alzheimer's disease research and treatments (41 papers) and melanin and skin pigmentation (29 papers). Luigi Bubacco is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (86 papers), Alzheimer's disease research and treatments (41 papers) and melanin and skin pigmentation (29 papers). Luigi Bubacco collaborates with scholars based in Italy, United States and United Kingdom. Luigi Bubacco's co-authors include Marco Bisaglia, Elisa Greggio, Stefano Mammi, Nicoletta Plotegher, Isabella Tessari, Mariano Beltramini, Isabella Russo, Marco Brucale, Gerard W. Canters and Laura Civiero and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Luigi Bubacco

194 papers receiving 7.6k citations

Hit Papers

Triggering of Inflammasome by Aggregated α–Synuclein, an ... 2013 2026 2017 2021 2013 2019 100 200 300 400

Peers

Luigi Bubacco
Kim A. Caldwell United States
Guy A. Caldwell United States
Julie K. Andersen United States
David Eliezer United States
Kah‐Leong Lim Singapore
Luigi Bubacco
Citations per year, relative to Luigi Bubacco Luigi Bubacco (= 1×) peers Fabio A. Zucca

Countries citing papers authored by Luigi Bubacco

Since Specialization
Citations

This map shows the geographic impact of Luigi Bubacco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Bubacco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Bubacco more than expected).

Fields of papers citing papers by Luigi Bubacco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Bubacco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Bubacco. The network helps show where Luigi Bubacco may publish in the future.

Co-authorship network of co-authors of Luigi Bubacco

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Bubacco. A scholar is included among the top collaborators of Luigi Bubacco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Bubacco. Luigi Bubacco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giusto, Elena, Lucia Iannotta, Ludovica Iovino, et al.. (2024). Prospective Role of PAK6 and 14-3-3γ as Biomarkers for Parkinson’s Disease. Journal of Parkinson s Disease. 14(3). 495–506.
2.
Masato, Anna, Annapaola Andolfo, Edoardo Bellini, et al.. (2024). Sequestosome-1 (SQSTM1/p62) as a target in dopamine catabolite-mediated cellular dyshomeostasis. Cell Death and Disease. 15(6). 424–424. 1 indexed citations
3.
Campagnolo, Marta, Luca Weis, Michele Sandre, et al.. (2024). Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort. Neurobiology of Disease. 200. 106609–106609. 3 indexed citations
4.
Masato, Anna & Luigi Bubacco. (2024). The αSynuclein half-life conundrum. Neurobiology of Disease. 196. 106524–106524. 1 indexed citations
5.
Bacchella, Chiara, Francesca Camponeschi, Isabella Tessari, et al.. (2023). Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment. Biomolecules. 13(2). 287–287. 12 indexed citations
6.
Masato, Anna, Nicoletta Plotegher, Michele Sandre, et al.. (2023). DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease. npj Parkinson s Disease. 9(1). 42–42. 28 indexed citations
7.
Carmosino, Monica, Andrea Gerbino, Anna Masato, et al.. (2023). Neuroprotective Effect of Antiapoptotic URG7 Protein on Human Neuroblastoma Cell Line SH-SY5Y. International Journal of Molecular Sciences. 25(1). 481–481. 1 indexed citations
8.
Cogo, Susanna, Elena Tosoni, James E. Tomkins, et al.. (2022). The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation. Brain Research. 1778. 147781–147781. 7 indexed citations
9.
Varanita, Tatiana, Jeroen Kole, René J. P. Musters, et al.. (2021). α‐Synuclein evokes NLRP3 inflammasome‐mediated IL‐1β secretion from primary human microglia. Glia. 69(6). 1413–1428. 84 indexed citations
10.
Sandre, Michele, Isabella Tessari, Nicoletta Plotegher, et al.. (2021). Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance. Molecular Neurobiology. 58(7). 3119–3140. 61 indexed citations
11.
Biosa, Alice, Irene Arduini, María Eugenia Soriano, et al.. (2018). Dopamine Oxidation Products as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson’s Disease. ACS Chemical Neuroscience. 9(11). 2849–2858. 45 indexed citations
12.
Russo, Isabella, Giulietta Di Benedetto, Alice Kaganovich, et al.. (2018). Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4. Journal of Neuroinflammation. 15(1). 297–297. 36 indexed citations
13.
Cogo, Susanna, Heather L. Melrose, Luigi Bubacco, et al.. (2016). LRRK2 deficiency impacts ceramide metabolism in brain. Biochemical and Biophysical Research Communications. 478(3). 1141–1146. 49 indexed citations
14.
Belluzzi, Elisa, Adriano Gonnelli, Antonella Marte, et al.. (2016). LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate. Molecular Neurodegeneration. 11(1). 1–1. 135 indexed citations
15.
Bubacco, Luigi, Anne Milet, Christian Philouze, et al.. (2013). Probing kojic acid binding to tyrosinase enzyme: insights from a model complex and QM/MM calculations. Chemical Communications. 50(3). 308–310. 26 indexed citations
16.
Tosatto, Laura, Nicoletta Plotegher, V. Antonini, et al.. (2012). Alpha-synuclein pore forming activity upon membrane association. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1818(11). 2876–2883. 82 indexed citations
17.
Greggio, Elisa, Laura Civiero, Marco Bisaglia, & Luigi Bubacco. (2012). Parkinson’s disease and immune system: is the culprit LRRKing in the periphery?. Journal of Neuroinflammation. 9(1). 94–94. 32 indexed citations
18.
Hirota, Shun, Mariano Beltramini, Paolo Di Muro, et al.. (2008). Molecular Basis of the Bohr Effect in Arthropod Hemocyanin. Journal of Biological Chemistry. 283(46). 31941–31948. 15 indexed citations
19.
Bubacco, Luigi, et al.. (2007). X-ray absorption analysis of the active site of Streptomyces antibioticus Tyrosinase upon binding of transition state analogue inhibitors. Archives of Biochemistry and Biophysics. 465(2). 320–327. 17 indexed citations
20.
Battaini, Giuseppe, Enrico Monzani, Luigi Casella, et al.. (2002). Tyrosinase-catalyzed Oxidation of Fluorophenols. Journal of Biological Chemistry. 277(47). 44606–44612. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026